Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up to $22.02

Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) gapped up before the market opened on Friday . The stock had previously closed at $22.02, but opened at $22.54. Fulgent Genetics shares last traded at $21.86, with a volume of 1,224 shares traded.

Fulgent Genetics Trading Up 0.7 %

The company’s 50-day moving average price is $20.77 and its 200-day moving average price is $22.67.

Fulgent Genetics (NASDAQ:FLGT) last issued its quarterly earnings data on Friday, May 3rd. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.20. Fulgent Genetics had a negative net margin of 57.72% and a negative return on equity of 2.92%. The company had revenue of $64.49 million during the quarter, compared to the consensus estimate of $65.74 million. On average, research analysts expect that Fulgent Genetics, Inc. will post -2.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. Illinois Municipal Retirement Fund boosted its holdings in Fulgent Genetics by 5.6% during the fourth quarter. Illinois Municipal Retirement Fund now owns 12,534 shares of the company’s stock worth $362,000 after purchasing an additional 668 shares during the last quarter. Asset Management One Co. Ltd. boosted its holdings in Fulgent Genetics by 60.8% during the fourth quarter. Asset Management One Co. Ltd. now owns 2,039 shares of the company’s stock worth $61,000 after purchasing an additional 771 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Fulgent Genetics by 34.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,569 shares of the company’s stock worth $190,000 after purchasing an additional 1,667 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in Fulgent Genetics by 11.0% during the first quarter. CANADA LIFE ASSURANCE Co now owns 29,103 shares of the company’s stock worth $631,000 after purchasing an additional 2,879 shares during the last quarter. Finally, SG Americas Securities LLC boosted its holdings in Fulgent Genetics by 36.4% during the second quarter. SG Americas Securities LLC now owns 12,826 shares of the company’s stock worth $252,000 after purchasing an additional 3,425 shares during the last quarter. Institutional investors and hedge funds own 48.06% of the company’s stock.

About Fulgent Genetics

Fulgent Genetics, Inc, together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases.